APA (7th ed.) Citation

Ponzetti C, Canciani M, Farina M, Era S, & Walzer S. (2016). Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey. Dove Medical Press.

Chicago Style (17th ed.) Citation

Ponzetti C, Canciani M, Farina M, Era S, and Walzer S. Potential Resource and Cost Saving Analysis of Subcutaneous Versus Intravenous Administration for Rituximab in Non-Hodgkin's Lymphoma and for Trastuzumab in Breast Cancer in 17 Italian Hospitals Based on a Systematic Survey. Dove Medical Press, 2016.

MLA (9th ed.) Citation

Ponzetti C, et al. Potential Resource and Cost Saving Analysis of Subcutaneous Versus Intravenous Administration for Rituximab in Non-Hodgkin's Lymphoma and for Trastuzumab in Breast Cancer in 17 Italian Hospitals Based on a Systematic Survey. Dove Medical Press, 2016.